Bentham Science Logo

Track Your Manuscript:

Current Psychopharmacology

Volume 10, 3 Issues, 2021
ISSN: 2211-5579 (Online)
ISSN: 2211-5560 (Print)
This journal supports open access


Current Psychopharmacology, Volume 3 - Number 2

Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review of Recent Data

, 3(2): 93 - 107

Silvio Bellino, Marta Mirra, Elena Brignolo, Paola Bozzatello and Filippo Bogetto

DOI: 10.2174/2211556003666140618185450

Increase in Antipsychotic Polypharmacy Treatment in Patients with Schizophrenia Between 1994-2000 and 2010

, 3(2): 108 - 112

Deniz Ceylan, Ahmet Aktener, Berna B. Akdede and Koksal Alptekin

DOI: 10.2174/221155600302150302110310

A Review of the Current Clinical Use of Quetiapine and Extended Release Quetiapine in the Management of Anxiety and Related Disorders

, 3(2): 113 - 125

Martin A. Katzman, Melissa Furtado, Alexandra Copeland, Dina Tsirgielis, Christina D’Ambrosio, Leena Anand and Irvin Epstein

DOI: 10.2174/221155600302150302110735

Maternal Exposure to Quetiapine: Effects on Structural Changes in Developing Brain and its Lasting Impact on Neurobehavioral Impairments in Rat Offspring

, 3(2): 137 - 145

Krishna P. Singh and Nidhi Tripathi

DOI: 10.2174/2211556003666140618184858


Kenneth Blum
Department of Psychiatry
Western University of Health Sciences
Pomona, CA
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Psychopharmacology was launched in 2012. Dr. Kenneth Blum serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog